- Are Besponsa and Blincyto the Same Thing?
- What Are Possible Side Effects of Besponsa?
- What Are Possible Side Effects of Blincyto?
- What Is Besponsa?
- What Is Blincyto?
- What Drugs Interact with Besponsa?
- What Drugs Interact with Blincyto?
- How Should Besponsa Be Taken?
- How Should Blincyto Be Taken?
Are Besponsa and Blincyto the Same Thing?
Besponsa (inotuzumab ozogamicin) for injection and Blincyto (blinatumomab) are monoclonal antibodies used to treat adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).
Side effects of Besponsa and Blincyto that are similar include low platelet counts (thrombocytopenia), low white blood cell counts (neutropenia, leukopenia), infection, anemia, fatigue, bleeding (such as nosebleeds), fever, chills, nausea, vomiting, headache, febrile neutropenia, abdominal pain, diarrhea, and constipation.
Side effects of Besponsa that are different from Blincyto include increased transaminases, swelling and sores inside the mouth, increased gamma-glutamyltransferase, and too much bilirubin in the blood.
Side effects of Blincyto that are different from Besponsa include swelling of extremities, tremor, rash, low blood potassium (hypokalemia), irregular heartbeats (arrhythmia), chest pain, weight gain, decreased appetite, back pain, pain in extremities, bone pain, joint pain, dizziness, insomnia, cough, shortness of breath, and high or low blood pressure (hypertension or hypotension).
Besponsa may interact with drugs known to prolong the QT interval or induce Torsades de Pointes.
What Are Possible Side Effects of Besponsa?
Common side effects of Besponsa include:
- low platelet counts (thrombocytopenia),
- low white blood cell counts (neutropenia, leukopenia),
- febrile neutropenia,
- transaminases increased,
- abdominal pain, diarrhea,
- swelling and sores inside the mouth,
- gamma-glutamyltransferase increased, and
- too much bilirubin in the blood
What Are Possible Side Effects of Blincyto?
Common side effects of Blincyto include:
- swelling of the extremities
- fever accompanying low levels of white blood cells (febrile neutropenia), and
- low levels of potassium in the blood (hypokalemia)
- low platelet levels in the blood
- low white blood cell count
- irregular heartbeats (arrhythmia)
- abdominal pain
- chest pain
- weight gain
- decreased appetite
- back pain
- pain in extremities
- bone pain
- joint pain
- shortness of breath
- high or low blood pressure (hypertension or hypotension)
What Is Besponsa?
Besponsa (inotuzumab ozogamicin) for injection is a CD22-directed antibody-drug conjugate (ADC) indicated for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).
What Is Blincyto?
Blincyto (blinatumomab) for injection is a bispecific CD19-directed CD3 T- cell engager indicated for the treatment of Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).
What Drugs Interact With Besponsa?
Besponsa may interact with drugs known to prolong the QT interval or induce Torsades de Pointes. Tell your doctor all medications and supplements you use.
What Drugs Interact With Blincyto?
Blincyto may interact with warfarin, cyclosporine, or other drugs. Tell your doctor all medications and supplements you use.
How Should Besponsa Be Taken?
The dose and cycle length for Besponsa depends on the cycle, the day of the cycle, and any prior response to treatment. Patients are pre-medicated with a corticosteroid, anti-fever medication, and antihistamine prior to all Besponsa infusions.
How Should Blincyto Be Taken?
Hospitalization is recommended for the first 9 days of the first cycle and the first 2 days of the second cycle of treatment with Blincyto. A single cycle of treatment with Blincyto consists of 4 weeks of continuous intravenous infusion followed by a 2-week treatment-free interval.
All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).
Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.
Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.
The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.
As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.
Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.
If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.
You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.
Amgen. Besponsa Product Information.